Ten drug recommendations by EMA

EMA’s human medicines committee (CHMP) recommended ten medicines for approval at its June 2024 meeting.

Consortium led by Evotec enters obesity drug space

Drug discovery CRO Evotec SE announced has entered into a partnership with Inserm, Lille University Hospital and Inserm Transfert to screen new biomarkers and targets in obesity and metabolic diseases.<br […]

Semarion Ltd. wins Ignite SME award at SLAS Europe

UK-based Semarion Ltd. was honoured as the most innovative company in the field of laboratory automation at SLAS Europe 2024 in Barcelona. <br /><br /><br />

MSD grabs Eyebiotech Ltd for US$1.3bn upfront

US pharma giant Merck Sharp &amp; Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones. <div></div>

SLAS Europe 2024 honours products with most impact

Swiss Seed Biosciences SA and UK-based Cryologyx Ltd have won the SLAS Europe Product Award 2024 for product developments with transformational potential for the sector.

Hornet Therapeutics reports first data of EBV-triggered disease blocker

Hornet Therapeutics Ltd will use a US$5m seed financing to launch clinical tests of its IDO1 blocker HTX-201within the next 12 to 18 months to target post-transplant lymphoproliferative disease.

AstraZeneca puts step into lucrative obesity market

Swiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc.

AstraZeneca puts step into obesity market

Swiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc.

Seed financing for Cellugy A/S

Danish industrial biotechnology startup Cellugy raises €4,9m with the ambition to replace petrochemicals in personal care products.<br /><br /><br />